Mariner Portfolio holdings
AUM
$69.3B
1-Year Return
18.98%
This Quarter Return
+2.43%
1 Year Return
+18.98%
3 Year Return
+74.86%
5 Year Return
+121.64%
10 Year Return
+220.27%
AUM
$59.6B
AUM Growth
+$3.19B
(+5.7%)
Cap. Flow
+$2.61B
Cap. Flow
% of AUM
4.38%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
3,565
New
280
Increased
1,860
Reduced
1,135
Closed
187
Top Buys
| 1 |
Tesla
TSLA
|
$373M |
| 2 |
NVIDIA
NVDA
|
$280M |
| 3 |
Apple
AAPL
|
$115M |
| 4 |
Invesco QQQ Trust
QQQ
|
$113M |
| 5 |
Corning
GLW
|
$105M |
Top Sells
| 1 |
Apollo Global Management
APO
|
$248M |
| 2 |
Microsoft
MSFT
|
$88.9M |
| 3 |
Ovintiv
OVV
|
$78.3M |
| 4 |
Enphase Energy
ENPH
|
$55.7M |
| 5 |
Walt Disney
DIS
|
$40.3M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 7.3% |
| 3 | Consumer Discretionary | 6.42% |
| 4 | Healthcare | 5.15% |
| 5 | Communication Services | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Globalstar
GSAT
$4.74B
| $29K | ﹤0.01% |
934
+221
| +31% | +$6.86K |
|
3327
Akebia Therapeutics
AKBA
$830M
| $28.4K | ﹤0.01% |
+14,944
| New | +$28.4K |
|
3328
Innoviz Technologies
INVZ
$365M
| $27.5K | ﹤0.01% |
16,390
+4,691
| +40% | +$7.88K |
|
|
PVL
3329
Permianville Royalty Trust
PVL
$65.7M
| $27K | ﹤0.01% |
+20,004
| New | +$27K |
|
|
KG
3330
Kestrel Group, Ltd.
KG
$198M
| $25.9K | ﹤0.01% |
765
-29
| -4% | -$980 |
|
|
NB
3331
NioCorp Developments
NB
$311M
| $25.3K | ﹤0.01% |
16,338
| – | – |
|
3332
Leslie's
LESL
$63.3M
| $25.2K | ﹤0.01% |
+11,291
| New | +$25.2K |
|
|
ICAD
3333
DELISTED
iCAD Inc
ICAD
| $24.7K | ﹤0.01% |
13,475
| – | – |
|
|
IMAB
3334
I-MAB
IMAB
$352M
| $24.4K | ﹤0.01% |
28,760
-2,775
| -9% | -$2.36K |
|
3335
Oxford Square Capital
OXSQ
$171M
| $24.4K | ﹤0.01% |
+10,010
| New | +$24.4K |
|
3336
Xilio Therapeutics
XLO
$36.2M
| $23.9K | ﹤0.01% |
25,000
-317
| -1% | -$303 |
|
3337
Chegg
CHGG
$166M
| $23.4K | ﹤0.01% |
14,545
-2,002
| -12% | -$3.22K |
|
|
SATX
3338
DELISTED
SatixFy Communications
SATX
| $23K | ﹤0.01% |
+15,000
| New | +$23K |
|
3339
Femasys
FEMY
$13.2M
| $20.6K | ﹤0.01% |
18,738
| – | – |
|
3340
Pyxis Oncology
PYXS
$118M
| $20.1K | ﹤0.01% |
+12,863
| New | +$20.1K |
|
3341
Alpha Tau Medical Warrant
DRTSW
$7.02M
| $19.7K | ﹤0.01% |
93,888
| – | – |
|
3342
Bolt Biotherapeutics
BOLT
$9.89M
| $18.7K | ﹤0.01% |
1,750
-277
| -14% | -$2.97K |
|
3343
Clearside Biomedical
CLSD
$26.8M
| $18K | ﹤0.01% |
18,950
| – | – |
|
3344
Compugen
CGEN
$137M
| $17.9K | ﹤0.01% |
11,690
-81
| -0.7% | -$124 |
|
3345
United Maritime
USEA
$14.9M
| $17.3K | ﹤0.01% |
+10,002
| New | +$17.3K |
|
|
AMRN
3346
Amarin Corp
AMRN
$308M
| $13.9K | ﹤0.01% |
+1,432
| New | +$13.9K |
|
3347
Coherus Oncology, Inc. Common Stock
CHRS
$160M
| $13.8K | ﹤0.01% |
10,000
| – | – |
|
|
URG
3348
Ur-Energy
URG
$533M
| $13.8K | ﹤0.01% |
+11,998
| New | +$13.8K |
|
|
SBLX
3349
StableX Technologies, Inc. Common Stock
SBLX
$3.55M
| $13.7K | ﹤0.01% |
1,250
| – | – |
|
3350
MIRA Pharmaceuticals
MIRA
$26.3M
| $13.1K | ﹤0.01% |
+11,500
| New | +$13.1K |
|